In silico evaluation of phenolic compounds as inhibitors of Α-amylase and Α-glucosidase

I Abdelli, N Benariba, S Adjdir, Z Fekhikher… - Journal of …, 2021 - Taylor & Francis
The aim of the present study focuses on the molecular docking approach to screen
alternative drug that can regulate the hyperglycemia by down-regulating α-glucosidase and …

[PDF][PDF] In silico evaluation of phenolic compounds as inhibitors of α-amylase and α-glucosidase

I Abdelli, N Benariba, S Adjdir, Z Fekhikher, I Daoud… - 2020 - academia.edu
The aim of the present study focuses on the molecular docking approach to screen
alternative drug that can regulate the hyperglycemia by down-regulating α-glucosidase and …

In silico evaluation of phenolic compounds as inhibitors of Α-amylase and Α-glucosidase.

I Abdelli, N Benariba, S Adjdir, Z Fekhikher… - … Structure & Dynamics, 2020 - europepmc.org
The aim of the present study focuses on the molecular docking approach to screen
alternative drug that can regulate the hyperglycemia by down-regulating α-glucosidase and …

In silico evaluation of phenolic compounds as inhibitors of Α-amylase and Α-glucosidase

I Abdelli, N Benariba, S Adjdir… - Journal of …, 2021 - ingentaconnect.com
The aim of the present study focuses on the molecular docking approach to screen
alternative drug that can regulate the hyperglycemia by down-regulating α-glucosidase and …

[PDF][PDF] In silico evaluation of phenolic compounds as inhibitors of α-amylase and α-glucosidase

I Abdelli, N Benariba, S Adjdir, Z Fekhikher, I Daoud… - 2020 - researchgate.net
The aim of the present study focuses on the molecular docking approach to screen
alternative drug that can regulate the hyperglycemia by down-regulating α-glucosidase and …

In silico evaluation of phenolic compounds as inhibitors of Α-amylase and Α-glucosidase

I Abdelli, N Benariba, S Adjdir… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
The aim of the present study focuses on the molecular docking approach to screen
alternative drug that can regulate the hyperglycemia by down-regulating α-glucosidase and …